financetom
Business
financetom
/
Business
/
Kennedy Wilson posts Q3 net loss 
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Kennedy Wilson posts Q3 net loss 
Nov 5, 2025 2:05 PM

Overview

* Kennedy Wilson Q3 adjusted EBITDA beats analyst expectations, indicating improved operational performance

* Company reports GAAP net loss of $21.2 mln, reduced from $77.4 mln in Q3-24

Outlook

* Kennedy Wilson to acquire Toll Brothers Apartment Living, deal pending, expects to add $5 bln in AUM

Result Drivers

* ASSET SALES - Generated $192 mln in cash from asset sales and recapitalizations in Q3-25, exceeding annual target

* INVESTMENT MANAGEMENT FEES - Increased 8% due to higher Fee-Bearing Capital and loan originations

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q3 EPS -$0.15

Q3 $18 mln

Adjusted

Net

Income

Q3 Beat $125.2 $100.3

Adjusted mln mln (1

EBITDA Analyst)

Analyst Coverage

* The current average analyst rating on the shares is "hold" and the breakdown of recommendations is no "strong buy" or "buy", 2 "hold" and no "sell" or "strong sell"

* The average consensus recommendation for the real estate rental, development & operations peer group is "buy."

* Wall Street's median 12-month price target for Kennedy-Wilson Holdings Inc ( KW ) is $8.35, about 10.5% above its November 4 closing price of $7.47

Press Release:

For questions concerning the data in this report, contact [email protected]. For any other questions or feedback, contact .

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Banco do Brasil ready to handle 'complex' issues amid debate over US sanctions
Banco do Brasil ready to handle 'complex' issues amid debate over US sanctions
Aug 20, 2025
BRASILIA, Aug 19 (Reuters) - Banco do Brasil said on Tuesday it is prepared to deal with complex, sensitive issues involving global regulations after a top court justice ruled foreign laws cannot be automatically applied in Brazil. The statement followed a Reuters query about the U.S. Magnitsky Act, which President Donald Trump used last month to sanction Supreme Court Justice...
US oil and gas M&A activity tripled last year, report says
US oil and gas M&A activity tripled last year, report says
Aug 20, 2025
NEW YORK (Reuters) -Mergers and acquisitions in the U.S. oil and gas sector tripled last year despite softer commodity prices as energy companies boosted spending to improve efficiency and profits, according to a report released on Tuesday. WHY IT'S IMPORTANT The jump in dealmaking marks a shift in strategy after years of focusing on shareholder returns over growth as commodity...
US soybean farmers urge Trump to make purchase deal with China
US soybean farmers urge Trump to make purchase deal with China
Aug 20, 2025
WASHINGTON (Reuters) -U.S. soybean farmers urged President Donald Trump in a Tuesday letter to reach a trade deal with China that secures significant soybean purchase agreements, warning of dire long-term economic outcomes if the country continues to shun the U.S. crop.  China, the world's largest soybean buyer, is turning to Brazilian cargoes amid trade tensions with the U.S. and ongoing negotiations....
FDA Extends Decision Date On Regenxbio's Gene Therapy Into Next Year
FDA Extends Decision Date On Regenxbio's Gene Therapy Into Next Year
Aug 20, 2025
The U.S. Food and Drug Administration (FDA) on Monday extended its review timeline for REGENXBIO Inc.’s Biologics License Application (BLA) for clemidsogene lanparvovec (RGX-121) for Mucopolysaccharidosis II (MPS II), also known as Hunter syndrome. The Prescription Drug User Fee Act (PDUFA) goal date has been extended from November 9, 2025, to February 8, 2026. The extension follows the company’s submission...
Copyright 2023-2026 - www.financetom.com All Rights Reserved